Silverfin false false 31/12/2024 31/12/2024 01/01/2024 no description of principal activity M English 07871826 2024-12-31 07871826 2023-12-31 07871826 core:CurrentFinancialInstruments 2024-12-31 07871826 core:CurrentFinancialInstruments 2023-12-31 07871826 2024-01-01 2024-12-31 07871826 bus:Micro-entities 2024-01-01 2024-12-31 07871826 bus:FilletedAccounts 2024-01-01 2024-12-31 07871826 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 07871826 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07871826 bus:Director1 2024-01-01 2024-12-31 07871826 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure

Company No: 07871826 (England and Wales)

PHARMA REGULATORY SUPPORT SERVICES LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2024
Pages for filing with the registrar

PHARMA REGULATORY SUPPORT SERVICES LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 December 2024

Contents

PHARMA REGULATORY SUPPORT SERVICES LIMITED

COMPANY INFORMATION

For the financial year ended 31 December 2024
PHARMA REGULATORY SUPPORT SERVICES LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2024
Director M English
Registered office 37 St Margaret's Street
Canterbury
CT1 2TU
United Kingdom
Company number 07871826 (England and Wales)
Accountant Kreston Reeves LLP
37 St Margarets Street
Canterbury
Kent
CT1 2TU

ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF PHARMA REGULATORY SUPPORT SERVICES LIMITED

For the financial year ended 31 December 2024

ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF PHARMA REGULATORY SUPPORT SERVICES LIMITED (continued)

For the financial year ended 31 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Pharma Regulatory Support Services Limited for the financial year ended 31 December 2024 which comprise the Balance Sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/regulation.

It is your duty to ensure that Pharma Regulatory Support Services Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Pharma Regulatory Support Services Limited. You consider that Pharma Regulatory Support Services Limited is exempt from the statutory audit requirement for the financial year.

We have not been instructed to carry out an audit or a review of the financial statements of Pharma Regulatory Support Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

This report is made solely to the director of Pharma Regulatory Support Services Limited, as a body, in accordance with the terms of our engagement letter dated 08 March 2024. Our work has been undertaken solely to prepare for your approval the financial statements of Pharma Regulatory Support Services Limited and state those matters that we have agreed to state to the director of Pharma Regulatory Support Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pharma Regulatory Support Services Limited and its director as a body for our work or for this report.

Kreston Reeves LLP
Chartered Accountants

37 St Margarets Street
Canterbury
Kent
CT1 2TU

25 March 2025

PHARMA REGULATORY SUPPORT SERVICES LIMITED

BALANCE SHEET

As at 31 December 2024
PHARMA REGULATORY SUPPORT SERVICES LIMITED

BALANCE SHEET (continued)

For the financial year ended 31 December 2024
2024 2023
£ £
Fixed assets 485 351
Current assets 70,022 68,062
Creditors: amounts falling due within one year ( 11,794) ( 12,472)
Net current assets 58,228 55,590
Total assets less current liabilities 58,713 55,941
Accruals and deferred income ( 8,454) ( 8,375)
Net assets 50,259 47,566
Capital and reserves 50,259 47,566

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Pharma Regulatory Support Services Limited (registered number: 07871826) were approved and authorised for issue by the director on 25 March 2025 and were signed on its behalf by:

M English
Director
PHARMA REGULATORY SUPPORT SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
PHARMA REGULATORY SUPPORT SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 December 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 07871826). The address of its registered office is 37 St Margaret's Street, Canterbury, CT1 2TU, United Kingdom.

The financial statements are rounded to the nearest Pound.

The company's functional and presentational currency is Pounds Sterling.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including the director 1 1